PARP-1 inhibitors in cancer therapy: design, molecular modeling, structure–activity relationships, and clinical advances. - Abdullah, Rosine; Ewida, Menna A.; Fawzy, Iten M.; Hagras, Mohamed; Refaat, Hanan M.; Ismail, Nasser S. M. (Future Journal of Pharmaceutical Sciences, 2026)